Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-09 | 2023-01-18 | 162271 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-06-09 | 2022-12-08 | 162274 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-06-09 | 2022-08-20 | 162277 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162280 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
| TEVA-CAPTOPRIL | 12.5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162286 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2022-06-09 | 2022-07-26 | 162291 |
| TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2022-06-09 | 2022-08-20 | 162297 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162300 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-06-09 | 2022-11-12 | 162306 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2022-06-09 | 2023-04-28 | 162309 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-16 | 2023-04-28 | 162846 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2022-06-16 | 2022-09-23 | 162849 |
| TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2022-06-16 | 2022-08-09 | 162852 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2022-06-16 | 2023-07-06 | 162855 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-06-16 | 2022-10-29 | 162858 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-06-16 | 2022-09-08 | 162861 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162864 |
| TEVA-QUININE | 200MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162867 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |